Conventional Therapy of Sjogren’s Syndrome
Identifieur interne : 001B69 ( Main/Exploration ); précédent : 001B68; suivant : 001B70Conventional Therapy of Sjogren’s Syndrome
Auteurs : Clio P. Mavragani [États-Unis] ; Haralampos M. Moutsopoulos [Grèce]Source :
- Clinical Reviews in Allergy & Immunology [ 1080-0549 ] ; 2007-06-01.
English descriptors
Abstract
Abstract: Sjogren’s syndrome (SS) is a chronic autoimmune disorder affecting mainly middle-aged women. It is characterized by lymphocytic infiltration and destruction of the exocrine glands (mainly the salivary and lacrimal glands), resulting in dry mouth and eyes. Symptoms of SS are chronic and sometimes devastating, compromising the quality of life at a major extent. Despite its autoimmune nature, evidence for the use of immunosuppressive agents, which are the mainstay of therapy of diseases of autoimmune origin, is limited. Keratoconjunctivitis sicca (KCS), the main ocular manifestation of SS, is managed with tear substitutes, as well as local and systemic stimulators of tear secretion and supportive surgical procedures. Management of oral manifestations includes intense oral hygiene, prevention and treatment of oral infections, use of saliva substitutes, and local and systematic stimulation of salivary secretion. Cholinergic agents, such as pilocarpine and cevimeline are the cornerstone of current therapy in SS. Corticosteroids, cyclophoshamide, and nucleoside analogues are reserved for severe extraglandular manifestations of SS. The role of anti-B-cell therapy is a promising option for glandular and extraglandular manifestations of the disease, as well as for the management of SS-associated lymphoma.
Url:
DOI: 10.1007/s12016-007-8008-3
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000F56
- to stream Istex, to step Curation: 000F56
- to stream Istex, to step Checkpoint: 000A52
- to stream Main, to step Merge: 001B80
- to stream Main, to step Curation: 001B69
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Conventional Therapy of Sjogren’s Syndrome</title><author><name sortKey="Mavragani, Clio P" sort="Mavragani, Clio P" uniqKey="Mavragani C" first="Clio P." last="Mavragani">Clio P. Mavragani</name></author><author><name sortKey="Moutsopoulos, Haralampos M" sort="Moutsopoulos, Haralampos M" uniqKey="Moutsopoulos H" first="Haralampos M." last="Moutsopoulos">Haralampos M. Moutsopoulos</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4FF4F94C79DC397B173335E28AE2B716437D5115</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1007/s12016-007-8008-3</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-62Q3GT69-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000F56</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F56</idno><idno type="wicri:Area/Istex/Curation">000F56</idno><idno type="wicri:Area/Istex/Checkpoint">000A52</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A52</idno><idno type="wicri:doubleKey">1080-0549:2007:Mavragani C:conventional:therapy:of</idno><idno type="wicri:Area/Main/Merge">001B80</idno><idno type="wicri:Area/Main/Curation">001B69</idno><idno type="wicri:Area/Main/Exploration">001B69</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Conventional Therapy of Sjogren’s Syndrome</title><author><name sortKey="Mavragani, Clio P" sort="Mavragani, Clio P" uniqKey="Mavragani C" first="Clio P." last="Mavragani">Clio P. Mavragani</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hospital for Special Surgery, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Moutsopoulos, Haralampos M" sort="Moutsopoulos, Haralampos M" uniqKey="Moutsopoulos H" first="Haralampos M." last="Moutsopoulos">Haralampos M. Moutsopoulos</name><affiliation wicri:level="3"><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Pathophysiology, Medical School, National University of Athens, M. Asias 75, 11527, Athens</wicri:regionArea><placeName><settlement type="city">Athènes</settlement><region nuts="2" type="region">Attique (région)</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Grèce</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Reviews in Allergy & Immunology</title><title level="j" type="abbrev">Clinic Rev Allerg Immunol</title><idno type="ISSN">1080-0549</idno><idno type="eISSN">1559-0267</idno><imprint><publisher>Humana Press Inc</publisher><pubPlace>New York</pubPlace><date type="published" when="2007-06-01">2007-06-01</date><biblScope unit="volume">32</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="284">284</biblScope><biblScope unit="page" to="291">291</biblScope></imprint><idno type="ISSN">1080-0549</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1080-0549</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Conventional treatment</term><term>Sicca features</term><term>Sjogren’s syndrome</term><term>Therapy</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Sjogren’s syndrome (SS) is a chronic autoimmune disorder affecting mainly middle-aged women. It is characterized by lymphocytic infiltration and destruction of the exocrine glands (mainly the salivary and lacrimal glands), resulting in dry mouth and eyes. Symptoms of SS are chronic and sometimes devastating, compromising the quality of life at a major extent. Despite its autoimmune nature, evidence for the use of immunosuppressive agents, which are the mainstay of therapy of diseases of autoimmune origin, is limited. Keratoconjunctivitis sicca (KCS), the main ocular manifestation of SS, is managed with tear substitutes, as well as local and systemic stimulators of tear secretion and supportive surgical procedures. Management of oral manifestations includes intense oral hygiene, prevention and treatment of oral infections, use of saliva substitutes, and local and systematic stimulation of salivary secretion. Cholinergic agents, such as pilocarpine and cevimeline are the cornerstone of current therapy in SS. Corticosteroids, cyclophoshamide, and nucleoside analogues are reserved for severe extraglandular manifestations of SS. The role of anti-B-cell therapy is a promising option for glandular and extraglandular manifestations of the disease, as well as for the management of SS-associated lymphoma.</div></front></TEI><affiliations><list><country><li>Grèce</li><li>États-Unis</li></country><region><li>Attique (région)</li><li>État de New York</li></region><settlement><li>Athènes</li></settlement></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Mavragani, Clio P" sort="Mavragani, Clio P" uniqKey="Mavragani C" first="Clio P." last="Mavragani">Clio P. Mavragani</name></region></country><country name="Grèce"><region name="Attique (région)"><name sortKey="Moutsopoulos, Haralampos M" sort="Moutsopoulos, Haralampos M" uniqKey="Moutsopoulos H" first="Haralampos M." last="Moutsopoulos">Haralampos M. Moutsopoulos</name></region><name sortKey="Moutsopoulos, Haralampos M" sort="Moutsopoulos, Haralampos M" uniqKey="Moutsopoulos H" first="Haralampos M." last="Moutsopoulos">Haralampos M. Moutsopoulos</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4FF4F94C79DC397B173335E28AE2B716437D5115
|texte= Conventional Therapy of Sjogren’s Syndrome
}}
| This area was generated with Dilib version V0.6.33. |  |